Causes of Elevated Liver Function Tests During Pregnancy
Elevated liver function tests during pregnancy are primarily caused by pregnancy-specific liver disorders, but can also result from pre-existing or coincidental liver diseases, requiring prompt investigation to reduce maternal and fetal morbidity and mortality. 1
Pregnancy-Specific Liver Disorders
First Trimester
- Hyperemesis Gravidarum
- Characterized by intractable vomiting leading to dehydration
- Affects up to 50% of patients with liver dysfunction in first trimester 2
- Typically presents with mild transaminase elevations
Second and Third Trimester
Intrahepatic Cholestasis of Pregnancy (ICP)
Preeclampsia and HELLP Syndrome
- Occurs after 20 weeks gestation 3
- Features: hypertension, proteinuria, elevated liver enzymes
- HELLP syndrome includes hemolysis, elevated liver enzymes, and low platelets
- Most common cause of hepatic tenderness and liver dysfunction in late pregnancy 4
- Accounts for 28.3% of third-trimester liver dysfunction 2
Acute Fatty Liver of Pregnancy (AFLP)
- Rare but catastrophic condition (0.01% of pregnancies) 1
- Typically occurs in third trimester
- Characterized by microvesicular fatty infiltration of hepatocytes
- Can progress to acute liver failure with coagulopathy and encephalopathy
- Accounts for 14.8% of third-trimester liver dysfunction 2
- Requires immediate delivery for maternal and fetal survival 4
Pre-existing and Coincidental Liver Diseases
Viral Hepatitis
- Most common cause of abnormal LFTs in second trimester (47%) 2
- Includes hepatitis A, B, C, and E
- Requires serological testing (HBsAg, anti-HCV, IgM anti-HEV, IgM anti-HAV) 2
Gallstone Disease
- Pregnancy increases risk of gallstone formation due to decreased gallbladder motility 1
- Can cause biliary colic, cholecystitis, or choledocholithiasis with elevated LFTs
Autoimmune Liver Disease
- Pre-existing autoimmune hepatitis may flare during pregnancy or postpartum
- Requires continued immunosuppressive therapy throughout pregnancy 3
Non-alcoholic Fatty Liver Disease (NAFLD)
- Found in 16-18% of pregnant women 5
- Associated with obesity, diabetes, and metabolic syndrome
- May explain many cases of "idiopathic" abnormal liver function in pregnancy 5
- Increases risk of pregnancy complications and abnormal fetal growth
Drug-Induced Liver Injury
- Careful medication history is essential
- Prescribed, over-the-counter medications, and herbal products should be reviewed 1
Diagnostic Approach
Initial Laboratory Evaluation
- Complete blood count with platelets
- Comprehensive metabolic panel
- Coagulation studies
- Total serum bile acids
- Hepatitis serologies 3
Imaging
- Ultrasound is first-line and safest option in pregnancy
- MRI without contrast if further evaluation is needed 3
- Avoid CT due to radiation exposure
Important Considerations
Normal vs. Abnormal Values
- Any elevation in aminotransferases, bilirubin, or bile acids during pregnancy is abnormal and requires investigation 1
- Normal physiological changes in pregnancy include:
- Increased alkaline phosphatase (placental origin)
- Decreased albumin (hemodilution)
- Increased alpha-fetoprotein 1
Clinical Pitfalls
- Delayed diagnosis can lead to increased maternal and fetal morbidity and mortality
- Attributing all liver enzyme elevations to pregnancy without considering non-pregnancy related causes
- Failure to monitor bile acid levels in ICP
- Inadequate postpartum follow-up 3
Timing of Presentation
Understanding the typical timing of pregnancy-specific liver disorders helps narrow the differential diagnosis:
- First trimester: Hyperemesis gravidarum
- Second trimester: Viral hepatitis, early ICP
- Third trimester: ICP, preeclampsia/HELLP, AFLP 1
Postpartum Follow-up
- Essential to ensure resolution of pregnancy-related liver diseases
- Persistent abnormalities beyond 6 weeks postpartum warrant evaluation for underlying chronic liver disease 1
Abnormal liver function tests in pregnancy affect 3-5% of pregnancies and require prompt and thorough evaluation to distinguish between pregnancy-specific disorders and coincidental liver diseases to guide appropriate management and improve maternal and fetal outcomes 6.